Response by Zinman et al to Letter Regarding Article, “Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.